Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Rupintrivir (AG7088)

Drug (Brand / Generic)

Rupintrivir (AG7088)

Company/Licensee

Agouron Pharmaceuticals (Pfizer subsidiary)

Therapy Class

Anti-viral agent

Product Description

Protease inhibitor

Current Indication

Treatment of colds due to rhinovirus infection

Market Sector

Anti-infectives

Development Status

Further development halted after failure in Phase II trials
Expand
Close
Close
Close

Go Top